Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Very nice upside in the making:
https://s3.amazonaws.com/b2icontent.irpass.cc/2648/rl112720.pdf
Any day now! > "Tingo expects to receive shareholder approval of the transaction and, following the mailing of an Information Statement to its shareholders, expects to close the transaction with MICT in the fourth quarter of 2022."
Live on Sunday Night, it's Bill Cunningham
Sunday, 9pm – Midnight EST
Tune in now > Republican Conservative
Law enforcement is now investigating a shooting at the home of Lee Zeldin, the Republican candidate for governor of New York.
Zeldin said his teenage children were doing homework when they heard gunshots.
He said in a statement: "After my daughters heard the gunshots and the screaming, they ran upstairs, locked themselves in the bathroom and immediately called 911. They acted very swiftly and smartly every step of the way and Diana and I are extremely proud of them. The two individuals who were shot were laying down under my front porch and the bushes in front of our porch. My understanding is that they have been transported to area hospitals. I do not know their identities."
'Look at that face!' Trump cries. 'Would anyone vote for that? Can you imagine that, the face of our next president? Trump referring to Carly Fiorina durling Republican Presidential debates.
Governor Ron DeSantis may be our next President !!!!!
OK > Looking to take a position again. Maybe on a FDA phase II or III approval. Possibly next year.
You may want to call the Transfer Agent. Let us know. Thank you!
PT > 15.00 ( Jefferies Maintains Buy on Provention Bio, Raises Price Target to $15
Jefferies analyst Chris Howerton maintains Provention Bio (NASDAQ:PRVB) with a Buy and raises the price target from $10 to $15.
Latest Ratings for PRVB DateFirmActionFromTo
Aug 2021OppenheimerMaintainsOutperform Aug 2021HC Wainwright & Co.MaintainsBuy Apr 2021Chardan CapitalMaintainsBuy
PRVB shares up after the company said it has entered into a co-promotion agreement with Sanofi U.S. for the launch of Provention's lead investigational drug candidate teplizumab.
The agreement enables Provention Bio to use Sanofi's expertise, capabilities and commercial resources to support the potential launch of teplizumab currently under review by the U.S. Food and Drug Administration, for the delay of clinical type 1 diabetes in at-risk individuals.
The company sees a user fee goal date of Nov. 17 for the Biologics License Application.
Under the terms of the agreement, Sanofi will commit commercial resources in the U.S, including diabetes field specialists, account directors, field-based reimbursement and medical science liaisons to expand the number of key healthcare professionals reached in the U.S. In exchange, Provention will reimburse field force-related expenses that Sanofi will incur in connection with commercializing teplizumab under the agreement.
Provention retains all rights to teplizumab and maintains responsibility for the commercialization strategy.
The company also granted Sanofi, in consideration of a one-time payment of $20 million, an exclusive, one-time right of first negotiation to obtain exclusive global rights to commercialize teplizumab for Type 1 diabetes indications in humans. Sanofi may exercise the ROFN, until June 30, 2023, with an option to extend within 2023 under certain conditions.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
NEW YORK, NY, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Tingo, Inc. (OTC Markets: TMNA) ("Tingo") and MICT, Inc. (NASDAQ: MICT) ("MICT") announced that they have amended and restated their Agreement and Plan of Merger to accelerate the acquisition by MICT of Tingo's operating business ("Tingo Mobile"). The transaction, which is being structured as a forward triangular merger of a newly formed holding company of Tingo Mobile into a subsidiary of MICT ("Merger"), provides for the issuance by MICT of a combination of common stock and two series of convertible preferred stock to Tingo in exchange for 100% beneficial ownership of Tingo Mobile and the assumption of certain liabilities of Tingo. Tingo expects to receive shareholder approval of the transaction and, following the mailing of an Information Statement to its shareholders, expects to close the transaction with MICT in the fourth quarter of 2022.
I am hearing from a neighboring town fire department that ( this year to date ) they have already responded to 16 garage fires . All are from electric tool packs, electric lawn mowers, and EV's.
Wow ! More fires: " as electric vehicle (EV) batteries corrode, fires begin" Never park an EV in your attached house/garage.
I never hear of gas & diesel engine vehicles with corroded batteries having fires.
Also, the salt water air along ocean beaches may corrode batteries.
LOL, Good one ! I LOVE LUCY . ( Nautica Eyewear)
Shelf placement: InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
8:00 am ET October 7, 2022 (BusinessWire) Print
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the sale and issuance of 523,810 shares of the Company's common stock (or pre-funded warrants in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. Concurrently with the registered direct offering, the Company entered into a definitive agreement with the investor in the registered direct offering for the sale and issuance of 1,190,476 shares of common stock (or pre-funded warrants in lieu thereof) in a private placement priced at-the-market under Nasdaq rules. In addition, the Company has agreed to issue to the investor in the offerings unregistered preferred investment options to purchase up to an aggregate of 1,714,286 shares of the Company's common stock. The preferred investment options have an exercise price of $5.05 per share, will be immediately exercisable upon issuance, and will expire five and one-half (5.5) years from the date of issuance. The combined purchase price for one share of common stock (or pre-funded warrant in lieu thereof) and the associated preferred investment option is $5.25.
I sold yesterday. Made nice profits! Keeping on my radar for any new developments.
Biden's Border Policies Are Reckless: I’m Fighting Back, but I Need Your Help. Donate Now! Don’t Take The Corporate Media’s Bait: They Just Want to Divide The GOP. Donate Now. Fight For Freedom. We Need Your Support. Don’t Let The Media Win. Fight The Liberal Machine. Become A DeSantis Donor. Make An Impact. Fight Back Against Biden. Back Florida’s Governor. Join The Fight.
NVIV Shares Resume Trading Following Circuit Breaker Halt. Up 64% today.
Chevron refinery production in Venezuela translates into revenues. Although this is a gamble in dealing with a dictator socialist regime. Retooling and start-up costs for a refinery runs into multimillion dollars.
Chevron refinery production in Venezuela translates into revenues. Although this is a gamble in dealing with a dictator socialist regime. Retooling and start-up costs for a refinery runs into multimillion dollars.
Venezuela sour crudes are heavy in sulfur content, requiring additional refining that typically needs natural gas, which has doubled in price this year. If the crude is not used, it could end up being stored in oil tanks or exported away and may not have the intended effect of reducing gasoline prices.
Venezuela sour crudes are heavy in sulfur content, requiring additional refining that typically needs natural gas, which has doubled in price this year. If the crude is not used, it could end up being stored in oil tanks or exported away and may not have the intended effect of reducing gasoline prices.
Nice volume! Tutes, mutual funds, University endowment funds, and pension funds are all buying their initial shares today, and going forward.
BHVN
LMAO! Well go ahead and import oil from Venezuela! Maybe Biden can get you a job working for Pete Buttegeg in the Tranny Dept.
Obviously you lack understanding, similar to Biden’s cognitive issues. The rest of the folks here understand that with USA exporting oil & nat gas, tens of thousands of jobs are created here in USA.
USA is sitting on several hundred year supply of natural gas and crude oil. USA needs a president that will enable our country to be the #1 petroleum exporter of supply to the world.
BHVN is a great $$$$$ opportunity.
$15.00+ by closing bell Friday !
Multitude of positive catalysts: " Broad therapeutic research and development portfolio includes more than 13 clinical and pre-clinical programs with a focus on neuroscience and rare disorders including epilepsy, pain and mood disorders, obsessive compulsive disorder (OCD), spinocerebellar ataxia (SCA) and spinal muscular atrophy (SMA).
Excitement mounting for clinical stage neuroscience program in Kv7 Ion Channel Modulation which targets key subunits involved in neuronal signaling and plays a critical role in regulating the hyperexcitable state in epilepsy and potentially other central nervous system (CNS) disorders.
Biohaven retains Board and key management team with established legacy of bringing the market-leading medicine Nurtec® ODT (rimegepant) to patients; Names Bruce Car, Ph.D. as Chief Scientific Officer; Irfan Qureshi, M.D. as Chief Medical Officer; and Tanya Fischer, M.D., Ph.D. as Chief Development Officer and Head of Translational Medicine.
NEW HAVEN, Conn., Oct. 4, 2022 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric diseases, including rare disorders, leveraging its proven drug development capabilities and proprietary technology platforms to advance a pipeline of best-in-class therapies. As of today, Biohaven has officially begun operating as a separate independent entity as part of the acquisition agreement with Pfizer in May 2022. The company, led by Vlad Coric, M.D. as Chairman and Chief Executive Officer, launched with approximately $257.8 million in cash at the distribution and no debt."
62nd HR ball has $2 million offer. Judge hit his 62nd home run in Game 2 of the Yankees’ doubleheader against the Rangers at Choctaw Stadium, and a lucky fan named Cory Youmans came away from the ball.
MORE ON:
AARON JUDGE
Aaron Judge gets rest day in season finale after hitting historic homer
Aaron Judge’s 62nd home run ball already has a $2 million offer
Aaron Judge’s historic 62nd home run in photos
Shop Aaron Judge jerseys on Amazon to celebrate his record-setting 62nd homer
As he was whisked around the stadium by security, Youmans was peppered with questions by reporters.
Asked what he was going to do with the ball, Youmans said, “That’s a good question! I haven’t thought about it!”
Upon a followup question where he was asked if he was going to keep the ball or give it back to Judge, Youmans, who was sporting a Texas Rangers cap, appeared to answer, “I don’t know.”
Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately $11.6 billion. As a result of the acquisition, Biohaven became a wholly-owned subsidiary of Pfizer.
Effective immediately prior to the closing of the acquisition, Biohaven completed the spin-off of Biohaven Ltd. (NYSE: BHVN), distributing Biohaven Ltd.’s shares to Biohaven’s shareholders. Biohaven Ltd., a new company that retained Biohaven’s non-CGRP development stage pipeline compounds, holds the Kv7 ion channel activators, glutamate modulation, and myostatin inhibition platforms, preclinical product candidates, and certain corporate infrastructure assets excluded from the Pfizer acquisition. Pfizer, a Biohaven shareholder, received a pro rata portion of Biohaven Ltd.’s shares in the distribution and owns approximately 3% of Biohaven Ltd. Biohaven Ltd. will continue to trade on the New York Stock Exchange under the ticker "BHVN".
CNTQ & BHVN > both moving up this afternoon!
New name > Biohaven Ltd.
BHVN up 39% @ 11.54 > Shares of Biohaven Ltd. rose by building on their debut surge from the previous day after the company was formally acquired by Pfizer Inc. and spun off.
The clinical-stage biopharmaceutical company and its Nurtec ODT migraine drug were acquired by Pfizer for $11.6 billion in cash and, immediately upon the closing of the acquisition, Biohaven was spun off into a separate entity. Pfizer owns about 3% of the new company.
As part of the acquisition, shareholders of the previous Biohaven received $148.50 a share in cash as well as shares of the new company, which retains the Biohaven moniker and its pipeline of non-calcitonin gene-related peptide programs.
The New Haven, Conn.-based company is launching anew with nearly $258 million in cash and no debt.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
BHVN up 39% @ 11.54 > Shares of Biohaven Ltd. rose by building on their debut surge from the previous day after the company was formally acquired by Pfizer Inc. and spun off.
The clinical-stage biopharmaceutical company and its Nurtec ODT migraine drug were acquired by Pfizer for $11.6 billion in cash and, immediately upon the closing of the acquisition, Biohaven was spun off into a separate entity. Pfizer owns about 3% of the new company.
As part of the acquisition, shareholders of the previous Biohaven received $148.50 a share in cash as well as shares of the new company, which retains the Biohaven moniker and its pipeline of non-calcitonin gene-related peptide programs.
The New Haven, Conn.-based company is launching anew with nearly $258 million in cash and no debt.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
Let's go BHVN !
Closes @ 14.00+ > Company is flush w/ cash and is partners with Pfizer.
Company has no debt.
Merger closes sometime in 2023.
Bounce! Your new porshe's shocks / ball joints are on warranty.
I believe all Doctor's offices, physical therapy centers, patient waiting rooms, hospital ED's , & school nurse's offices will have these Purgo air units.
AERC
Excellent! You are a very good trader!